Inactivation of Sema3E-PlexinD1 signaling has improved the recovery of cardiac function by increasing lymphangiogenesis in an adult mouse model of MI [83], suggesting a therapeutic possibility for targeting Sema3E-PlexinD1 signaling in cardiovascular diseases. The gene discussed is SEMA3E; the disease is cardiovascular disorder.